Product NDC: | 0409-2634 |
Proprietary Name: | Hydromorphone Hydrochloride |
Non Proprietary Name: | HYDROMORPHONE HYDROCHLORIDE |
Active Ingredient(s): | 10 mg/mL & nbsp; HYDROMORPHONE HYDROCHLORIDE |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0409-2634 |
Labeler Name: | Hospira, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA078591 |
Marketing Category: | ANDA |
Start Marketing Date: | 20100819 |
Package NDC: | 0409-2634-05 |
Package Description: | 10 VIAL, SINGLE-DOSE in 1 BOX (0409-2634-05) > 5 mL in 1 VIAL, SINGLE-DOSE |
NDC Code | 0409-2634-05 |
Proprietary Name | Hydromorphone Hydrochloride |
Package Description | 10 VIAL, SINGLE-DOSE in 1 BOX (0409-2634-05) > 5 mL in 1 VIAL, SINGLE-DOSE |
Product NDC | 0409-2634 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | HYDROMORPHONE HYDROCHLORIDE |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
Start Marketing Date | 20100819 |
Marketing Category Name | ANDA |
Labeler Name | Hospira, Inc. |
Substance Name | HYDROMORPHONE HYDROCHLORIDE |
Strength Number | 10 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |